Matthew Sander
About Matthew Sander
Matthew Sander is an Associate Director of Analytical Development and Quality Control at Aimmune Therapeutics, with extensive experience in the biopharmaceutical industry. He has held various roles in analytical development and quality control across several companies, including Dance Biopharm and Valeant Pharmaceuticals, and has a strong background in regulatory submissions and product development.
Work at Aimmune Therapeutics
Matthew Sander serves as the Associate Director of Analytical Development and Quality Control at Aimmune Therapeutics. He has held this position since 2017, contributing to the company's focus on drug/device combination products. His role involves overseeing analytical development processes and ensuring compliance with quality control standards in the development of biopharmaceuticals.
Previous Experience in Biopharmaceuticals
Prior to his current role, Matthew Sander worked at Dance Biopharm as a Senior Manager in Development for seven months in 2015 and 2016. He also held the position of Senior R&D Chemist at the same company from 2014 to 2015. His earlier experience includes working as an Analytical Chemist at Valeant Pharmaceuticals from 2007 to 2011 and as a Senior R&D Chemist at Insite Vision, Inc. from 2012 to 2014.
Education and Expertise
Matthew Sander studied at the University of California, Berkeley, where he earned a Bachelor's degree in Biochemistry from 2002 to 2005. He furthered his education at the University of California, San Francisco, obtaining a Master's degree in Medicine from 2011 to 2012. His expertise includes 3D modeling and engineering specifications for medical technology product development, as well as a strong background in intellectual property development and regulatory submissions.
Regulatory Submissions and Specializations
Matthew Sander specializes in drug/device combination products, with a focus on preclinical testing and regulatory submissions. His experience includes working with submissions such as 510(k) and PMA, as well as IND, CMC, and NDA for biotech products. This background supports his role in ensuring that products meet regulatory requirements throughout the development process.
Early Career and Research Experience
Matthew Sander began his career with a research assistant position at UC Berkeley in 2005. He also worked briefly as a QC Research Associate at Bayer in Germany in 2006. These early experiences provided him with foundational skills in research and quality control that have contributed to his subsequent roles in the biopharmaceutical industry.